Pentwater Capital Management LP Pure Tech Health PLC Transaction History
Pentwater Capital Management LP
- $15.9 Billion
- Q3 2025
A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 75,000 shares of PRTC stock, worth $1.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,000
Previous 50,000
50.0%
Holding current value
$1.21 Million
Previous $862,000
60.9%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
102KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny17.8KShares$288,3100.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$118,3550.03% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$27,2290.02% of portfolio
-
Ubs Group Ag20Shares$3230.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M02Shares$320.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $451M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...